SEC Form 4 research
| Issuer | Eton Pharmaceuticals, Inc. |
|---|---|
| Tickers | ETON |
| Reporting owners | 14 |
| Officers and directors | 7 |
| Last public filing | 2026-10-06 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-06 | 2026-10-06 | Krempa David | S | 4,166 | $55.07 | Not reported |
| 2026-08-31 | 2026-08-28 | MAIER PAUL V | S | 128 | $61.77 | Not reported |
| 2026-08-31 | 2026-08-28 | MAIER PAUL V | S | 13,485 | $60.21 | Not reported |
| 2026-08-31 | 2026-08-28 | MAIER PAUL V | S | 36,387 | $58.64 | Not reported |
| 2026-08-28 | 2026-08-28 | MAIER PAUL V | S | 128 | $61.77 | Not reported |
| 2026-08-28 | 2026-08-28 | MAIER PAUL V | S | 13,485 | $60.21 | Not reported |
| 2026-08-28 | 2026-08-28 | MAIER PAUL V | S | 36,387 | $58.64 | Not reported |
| 2026-08-24 | 2026-08-24 | Krempa David | S | 25,000 | $65.07 | Not reported |
| 2026-08-20 | 2026-08-20 | BRYNJELSEN SEAN | S | 7,342 | $62.12 | Not reported |
| 2026-08-20 | 2026-08-20 | BRYNJELSEN SEAN | S | 36,373 | $61.11 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.